India · Delayed Price · Currency is INR Brooks Laboratories Statistics
Total Valuation
BOM:533543 has a market cap or net worth of INR 1.77 billion. The enterprise value is 1.79 billion.
| Market Cap | 1.77B |
| Enterprise Value | 1.79B |
Important Dates
The last earnings date was Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 29.46M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.98% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 54.86% |
| Owned by Institutions (%) | 11.06% |
| Float | 13.30M |
Valuation Ratios
The trailing PE ratio is 13.38.
| PE Ratio | 13.38 |
| Forward PE | n/a |
| PS Ratio | 2.12 |
| PB Ratio | 1.44 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | 30.54 |
| P/OCF Ratio | 19.02 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.94, with an EV/FCF ratio of 30.86.
| EV / Earnings | 13.52 |
| EV / Sales | 2.15 |
| EV / EBITDA | 11.94 |
| EV / EBIT | 13.35 |
| EV / FCF | 30.86 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 1.35 |
| Debt / FCF | 1.47 |
| Interest Coverage | 7.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.81% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.40M |
| Profits Per Employee | 380,744 |
| Employee Count | 347 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.91% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -58.91% |
| 50-Day Moving Average | 66.72 |
| 200-Day Moving Average | 71.62 |
| Relative Strength Index (RSI) | 47.52 |
| Average Volume (20 Days) | 2,656 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533543 had revenue of INR 831.87 million and earned 132.12 million in profits. Earnings per share was 4.49.
| Revenue | 831.87M |
| Gross Profit | 344.70M |
| Operating Income | 47.39M |
| Pretax Income | 132.12M |
| Net Income | 132.12M |
| EBITDA | 59.71M |
| EBIT | 47.39M |
| Earnings Per Share (EPS) | 4.49 |
Balance Sheet
The company has 66.73 million in cash and 85.17 million in debt, with a net cash position of -18.44 million.
| Cash & Cash Equivalents | 66.73M |
| Total Debt | 85.17M |
| Net Cash | -18.44M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.23B |
| Book Value Per Share | 41.64 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 92.93 million and capital expenditures -35.06 million, giving a free cash flow of 57.88 million.
| Operating Cash Flow | 92.93M |
| Capital Expenditures | -35.06M |
| Depreciation & Amortization | 12.32M |
| Net Borrowing | 9.34M |
| Free Cash Flow | 57.88M |
| FCF Per Share | n/a |
Margins
Gross margin is 41.44%, with operating and profit margins of 5.70% and 15.88%.
| Gross Margin | 41.44% |
| Operating Margin | 5.70% |
| Pretax Margin | 15.88% |
| Profit Margin | 15.88% |
| EBITDA Margin | 7.18% |
| EBIT Margin | 5.70% |
| FCF Margin | 6.75% |
Dividends & Yields
BOM:533543 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.98% |
| Shareholder Yield | -5.98% |
| Earnings Yield | 7.48% |
| FCF Yield | 3.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |